Stronger Opening
Stocks appeared set to open higher
Wednesday.
All eyes on Wall Street and Main
Street will be on Greenspan, as he will be giving his Humphrey Hawkins testimony
today.
Bioject Medical
(
BJCT |
Quote |
Chart |
News |
PowerRating) said that
Amgen
(
AMGN |
Quote |
Chart |
News |
PowerRating) will not pursue the development of the B2000
equipment.
ICN Pharmaceuticals
(
ICN |
Quote |
Chart |
News |
PowerRating) posted
Q4 net earnings of 40 cents a share, beating estimates of 32 cents a share by
Wall Street analysts’.
AZZ
(
AZZ |
Quote |
Chart |
News |
PowerRating) lowered its earnings
estimates for fiscal year 2002 citing problems with cost overruns and postponed
projects. Earnings for the company should come in between $1.43 to $1.50 for the
fiscal year which ends at the end of the month.
Tweeter Home Entertainment Group
(
TWTR |
Quote |
Chart |
News |
PowerRating)
said same-store sales for Q2 are down approximately 8.5%.
Hanover Compressor
(
HC |
Quote |
Chart |
News |
PowerRating) was
upgraded by Credit Suisse First Boston from Buy to Strong Buy.
ABN Amro upgraded Western Wireless
(
WWCA |
Quote |
Chart |
News |
PowerRating)
from Add to Buy after last night’s earnings report.
Federated Department Stores
(
FD |
Quote |
Chart |
News |
PowerRating)
was upgraded by ABN Amro from Add to Buy after the company report for Q4.
J.P. Morgan upgraded Ariba
(
ARBA |
Quote |
Chart |
News |
PowerRating)
from Market Perform to Long Term Buy, citing the 12 month risk to reward scenario
is attractive at these levels after the company declined 47% over the last
month.
The FDA said it will consider
reviewing Imclone Systems’
(
IMCL |
Quote |
Chart |
News |
PowerRating) application to market Erbitux, IMCL’s
cancer drug, if the company resubmits US trial data in addition to the new
European trials data. This suggests that IMCL may not be subject to conducting a
new larger clinical trial.
Applebee’s International
(
APPB |
Quote |
Chart |
News |
PowerRating)
said same-store sales rose 4.6% in February.
Steve Madden
(
SHOO |
Quote |
Chart |
News |
PowerRating) reported
earnings of $2.7 million or 21 cents a share, excluding charge, vs. $4.5
million or 38 cents a share for the same quarter a year ago.